Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Pharmacol. 2002 Oct;2(5):541-7.

    Novel technologies for studying virus-host interaction and discovering new drug targets for HCV and HIV.

    Source

    Immusol Inc., San Diego, CA 92121, USA. tang@immusol.com

    Abstract

    A new paradigm for antiviral therapy focuses on targeting cellular genes that are critical for viral replication and pathogenesis. Several new technologies have contributed to the identification of such genes for human immunodeficiency virus and hepatitis C virus. These include proteomic approaches that identify cellular proteins that physically interact with viral proteins, genomic approaches that identify and functionally validate essential cellular co-factor genes, and novel cell biology systems that facilitate studies of virus-host interactions.

    PMID:
    12324256
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk